Strepomyces and Chemtrails
Chemtrails which fell to the ground revealed the presence of biological-agents: Pseudomonas Fluorescens, Streptomyces , and a restriction enzyme used to create viruses. (See this report).
The presence of Streptomyces was very unusual. Unlike the Flourescens, Streptomyces is almost nonexistent in outdoor samples. This fungus is used to make a variety of antibiotics, such as Streptomycin, Tetracycline, Tobramycin.
Streptomyces
From Wikipedia, the free encyclopedia
Streptomyces |
|
Slide culture of a Streptomyces species |
Scientific classification |
Kingdom: |
Bacteria |
Phylum: |
Actinobacteria |
Class: |
Actinobacteria |
Order: |
Actinomycetales |
Family: |
Streptomycetaceae |
Genus: |
Streptomyces
Waksman & Henrici 1943 |
Diversity |
About 550 species |
Synonyms |
Streptoverticillium |
Streptomyces is the largest genus of Actinobacteria and the type genus of the familyStreptomycetaceae.[1] Over 500 species of Streptomyces bacteria have been described.[2] As with the other Actinobacteria, streptomycetes are gram-positive, and have genomes with highGC-content.[3] Found predominantly in soil and decaying vegetation, most streptomycetes produce spores, and are noted for their distinct "earthy" odor which results from production of a volatile metabolite, geosmin.
Streptomycetes are characterised by a complex secondary metabolism.[3] They produce over two-thirds of the clinically useful antibiotics of natural origin (e.g., neomycin,chloramphenicol).[4] The now uncommonly-used streptomycin takes its name directly fromStreptomyces. Streptomycetes are infrequent pathogens, though infections in human such asmycetoma can be caused by S. somaliensis and S. sudanensis and in plants can be caused by S. caviscabies and S. scabies.
http://en.wikipedia.org/wiki/Streptomyces
Anti-Parasitic Compounds from Streptomyces sp. Strains Isolated from Mediterranean Sponges
Sheila Marie Pimentel-Elardo, 1,2* Svitlana Kozytska, 2 Tim S. Bugni, 3† Chris M. Ireland, 3 Heidrun Moll, 2 and Ute Hentschel 1,2
1 Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs Platz 3, 97082 Würzburg, Germany
2 Research Center for Infectious Diseases, Josef-Schneider-Straße 2, 97080 Würzburg, Germany
3 Department of Medicinal Chemistry, University of Utah, Salt Lake City, 84112 Utah, USA
*Author to whom correspondence should be addressed; E-Mail: sheila-marie.elardo@mail.uniwuerzburg. de; Tel.: 0049-931-31-86039; Fax: 0049-931-31-86235.
†Present address: School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA.
Received December 26, 2009; Revised February 2, 2010; Accepted February 4, 2010.
This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Abstract
Actinomycetes are prolific producers of pharmacologically important compounds accounting for about 70% of the naturally derived antibiotics that are currently in clinical use. In this study, we report on the isolation of Streptomyces sp. strains from Mediterranean sponges, on their secondary metabolite production and on their screening for anti-infective activities. Bioassay-guided isolation and purification yielded three previously known compounds namely, cyclic depsipeptide valinomycin, indolocarbazole alkaloid staurosporine and butenolide. This is the first report of the isolation of valinomycin from a marine source. These compounds exhibited novel anti-parasitic activities specifically against Leishmania major (valinomycin IC50 < 0.11 μM; staurosporine IC50 5.30 μM) and Trypanosoma brucei brucei (valinomycin IC50 0.0032 μM; staurosporine IC50 0.022 μM; butenolide IC50 31.77 μM). These results underscore the potential of marine actinomycetes to produce bioactive compounds as well as the re-evaluation of previously known compounds for novel anti-infective activities.
1. Introduction
The class Actinobacteria , specifically bacteria belonging to the order Actinomycetales , are common soil inhabitants that have the unprecedented ability to produce a wide range of secondary metabolites. Among the more than 140 described actinomycete genera, only a few are responsible for the majority of over 20,000 microbial natural products identified so far. In particular, the genus Streptomyces accounts for about 80% of the actinomycete natural products reported to date [ 1 , 2 ]. Given the unparalleled potential of actinomycetes and specifically streptomycetes in this regard, significant effort has been directed towards the isolation of these bacteria from various sources for drug screening programs. The majority of the actinomycetes were previously isolated from terrestrial soils and from marine sediments [ 3 – 5 ] and quite recently also from marine sponges [ 6 – 10 ] and cone snails [ 11 ]. The discovery of numerous marine actinomycete taxa and their bioactive secondary metabolites dispel the notion that actinomycetes are merely dormant spores that have been washed off from the shores [ 1 , 3 , 12 , 13 ].
The major goal of our research is to discover novel anti-infective agents such as those against the parasites Leishmania major and Trypanosoma brucei that cause leishmaniasis and African sleeping sickness, respectively. These parasites currently affect around 12 million people living in tropical and subtropical areas [ 14 ]. The alarming death rate caused by these parasites and the emergence of antibiotic resistance underline the need for new and effective drugs. Our research program focuses on the discovery of anti-infective agents from marine sponges and their associated microorganisms. In the course of our study, we have taxonomically described two new actinomycete species [ 15 , 16 ] isolated from marine sponges as well as novel compounds [ 17 ]. During our screening efforts for bioactive natural products from marine sponge-associated actinomycetes, we have encountered some previously known compounds but with yet unprecedented biological activities. We report here the isolation and characterization of these compounds from actinomycetes associated with Mediterranean sponges with novel anti-parasitic activities.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2852844/
Short Term Effects of Chemtrails:
- Allergies
- Anxiety
- Asthma
- Brain Fog
- Breathing difficulties (Unexplained)
- Chronic sore or raspy throat
- Dizziness
- Eye and skin irritations
- Flatulence (gas)
- Flu-like symptoms
- Headaches
- itching (Unexplained)
- Nausea and Vomiting
- Nose bleeds (Unexplained)
- Panic attacks
- Persistent coughing
- Respiratory problems
- Stomach aches
- Suicidal thoughts
- Tinnitus (distant ringing in ears or high pitched sound after spraying)
- And many other symptoms
Long Term Effects of Chemtrails:
- Acid Reflux
- (ADHD) Attention Deficit Hyperactivity Disorder
- Allergies
- Alzheimer's Disease
- Aluminum build up in Pineal Gland
- Asthma
- Autism (evidence links autism to mercury)
- Autoimmune Diseases
- Blood in the Urine
- Borderline personality disorder
- Cancer (linked to many types of cancers)
- Chronic Fatigue
- Constipation
- Depression
- Easy Bruising
- Eye problems - * Nearsightedness & Farsightedness (by altering interocular fluid eye
- pressure)
- Fibromyalgia
- Floaters In the Eyes
- Gastritis
- Heart Arrhythmia (irregular heartbeat)
- Heart Disease
- High Cholesterol
- Hypoglycemia
- Hyperglycemia
- Irritable Bowel Syndrome (IBS)
- Insomnia
- Learning Disabilities
- Lung diseases
- Lupus Erythematosus
- Multiple Sclerosis
- Oily Skin (Elevated DHT)
- Parkinson's Disease
- Rheumatoid Arthritis
- Schizophrenia
- Short-Term Memory Loss
- Sleep Disorders
- Spider Veins
- Tinnitus (ringing in the ears – 700 million cases of Tinnitus reported worldwide)
- White Coating On the Tongue
- And many other symptoms